![LOGO](https://capedge.com/proxy/8-K/0001193125-20-108733/g895056ex99_1.jpg)
COVID-19 Update
Schmitt has implemented COVID-19 response and business continuity plans to protect its employees and their families, to safeguard continuity of Schmitt operations, and to ensure full support to its customers and partners. For the time being, the Company has implemented new safety guidelines that maximize interpersonal space to protect employees working on location, while all other employees who can telecommute work remotely.
The Company is highly focused on retaining its workforce and leadership during these extraordinary times and will continue to evaluate the business environment and outlook to ensure preservation of enterprise value under a wide range of circumstances.
De-listing and Deregistration Update
Schmitt continues to evaluate a shareholder value opportunity in regard to the previously announced intent to delist. There can be no assurance that the Company will enter into an agreement relating to the transaction or as to the timing or the terms of such opportunity thereof or what impact of such opportunity would be on the trading of the Company’s common stock. To the extent that the Company elects to proceed with delisting, it will provide shareholders and NASDAQ ten days notice of any intent to file a Form 25.
Share Repurchases
On December 3, 2019, the Company announced that its Board of Directors authorized a share repurchase plan to buy up to $2 million of its Common Stock. Since the announcement, the Company has repurchased approximately 10% of its shares through both a private transaction for 365,490 shares at $3.25 per share and 46,932 shares at an average price of $3.10 per share, which was done in accordance with a 10b5-1 plan. At this time, the plan has been suspended pending the evaluation of the shareholder value opportunity discussed above. Due to the private transaction remaining outside of the $2m repurchase plan, $1.85 million remains available on the repurchase plan once resumed.
Summary data for the three months ended February 29 and 28, 2020 and 2019:
| | | | | | | | | | | | | | | | |
| | Three Months Ended February 29 and 28, | | | | | | | |
| | 2020 | | | 2019 | | | Change ($) | | | Change (%) | |
Total net revenue | | $ | 1,094,967 | | | $ | 1,120,545 | | | $ | (25,578 | ) | | | (2.3 | %) |
Gross margin | | | 55.1 | % | | | 37.1 | % | | | | | | | | |
Operating expenses | | $ | 1,035,322 | | | $ | 831,602 | | | $ | 203,720 | | | | 24.5 | % |
Net loss from continuing operations | | $ | (240,277 | ) | | $ | (423,963 | ) | | $ | 183,686 | | | | (43.3 | %) |
Net loss per fully diluted share from continuing operations | | $ | (0.06 | ) | | $ | (0.11 | ) | | $ | 0.04 | | | | (41.2 | %) |
Summary data for the nine months ended February 29 and 28, 2020 and 2019:
| | | | | | | | | | | | | | | | |
| | Nine Months Ended February 29 and 28, | | | | | | | |
| | 2020 | | | 2019 | | | Change ($) | | | Change (%) | |
Total net revenue | | $ | 3,222,846 | | | $ | 3,524,666 | | | $ | (301,820 | ) | | | (8.6 | %) |
Gross margin | | | 45.6 | % | | | 39.0 | % | | | | | | | | |
Operating expenses | | $ | 2,818,187 | | | $ | 2,435,661 | | | $ | 382,526 | | | | 15.7 | % |
Net loss from continuing operations | | $ | (1,138,481 | ) | | $ | (1,058,660 | ) | | $ | (79,821 | ) | | | 7.5 | % |
Net loss per fully diluted share from continuing operations | | $ | (0.29 | ) | | $ | (0.26 | ) | | $ | (0.02 | ) | | | 7.6 | % |
CORPORATE OFFICE: 2765NW NICOLAIST. • PORTLAND, OREGON 97210 • 503/227-7908 • FAX 503/223-1258